Researchers hope the findings will help identify common disease mechanisms and potential targets for future treatments.

A nationwide survey shows people seeking neurology care for memory concerns wait an average of 4 months, potentially preventing early Alzheimer's disease diagnosis and treatment. Medical News

RNA medicines can reduce the production of proteins involved in disease by acting on the messages cells use to make them. Their development has produced treatments for inherited nerve disorders, [···]

A tiny implant is providing a groundbreaking treatment for macular telangiectasia, a rare eye disease, by slowing or stopping its progression.

During Lung Cancer Awareness Month in November, researchers and clinicians at Fred Hutch Cancer Center are available to share insight on screening and prevention recommendations, new offerings in [···]

An innovative robotic device inspired by snake movement could someday help gastroenterologists diagnose and treat inflammatory bowel disease (IBD) and other disorders of the small intestine and [···]

The Huntington's Disease Foundation (HDF) has awarded $2 million for its 2026 Transformative Research Awards (TRAs) to support two exceptional research collaborations with the potential to advance [···]

Patients with rheumatoid arthritis who tapered treatment were more likely to experience disease flare.

Aspen Neuroscience is pursuing a $150 million IPO to fund Parkinson's Disease stem cell therapies.

The plan builds on recent FDA moves to speed 'personalized' treatments by offering an approval framework for therapies benefiting different subsets of patients with the same disease.

Protein-based medicines have transformed the treatment of many diseases, but they often come with a limitation: they must be injected, sometimes repeatedly, because they are rapidly cleared from the [···]

Anthropic has acquired a biotech startup with just one full-time employee that used Claude AI to develop an experimental treatment for a rare childhood muscle disease in under 18 months, producing [···]

Fusion to engineered albumin makes protein-based therapeutics long-acting and gives them the ability to cross mucosal barriers | !

Women with rheumatoid arthritis may have more active disease and poorer treatment responses, yet experts say the overall goal remains remission for both sexes.

Oct 28 (Reuters) - Biogen beat Wall Street estimates for third-quarter results on Wednesday, as strong demand for its rare disease and Alzheimer's drugs helped offset declining sales of its [···]

Protein-based medicines have transformed the treatment of many diseases, but they often come with a limitation: they must be injected, sometimes repeatedly, because they are rapidly cleared from the [···]

Malaria kills more than 600,000 children globally, and the parasite responsible for the disease is growing resistant to treatment. Scientists at The Wertheim UF Scripps Institute in Jupiter, [···]

Malaria kills more than 600,000 children globally, and the parasite responsible for the disease is growing resistant to treatment. Led by Ben Shen, Ph.D., a team at The Wertheim UF Scripps Institute [···]

As Stan Au's Parkinson's disease symptoms progressed, everyday activities became daily battles. His hands shook so badly that he struggled to hold utensils and couldn't sign his name. He stopped [···]

Protein patterns linked to TRL and Lp(a), two types of fat-carrying particles, suggest shared inflammatory pathways that could offer new targets for heart disease prevention. Lowering 'bad' [···]

Image Courtesy: News-Medical Scientists investigating a potential treatment for Alzheimer's disease have made an unexpected discovery: a peptide the

Naegleria fowleri, a brain-eating amoeba, is one of the most lethal infections in the world. Scientists at UC San Diego have isolated a molecule that could help us fight back. Credit [···]

Researchers in China have discovered that the vitamin B5 derivative pantethine limits the activity of immune cells that are key contributors to autoimmune diseases such as psoriasis. The study, to [···]

A more effective and better-tolerated treatment for chronic myeloid leukemia (CML) could improve quality of life for people living with the disease.

DENVER — Nearly half of missed dialysis treatments can be attributed to health issues that arise the day of treatment, and rescheduling is more likely when clinic staff actively follow-up, [···]

AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected [···]

A cancer advocacy group has warned that many patients in South Sudan are diagnosed at advanced stages of the disease, leaving them with limited treatment options.

Patients who develop cytokine release syndrome after chimeric antigen receptor T-cell therapy for autoimmune disease demonstrate significantly higher B-cell counts and interleukin-6 concentrations [···]

Patients with an advanced form of lung cancer lived 56 percent longer without their disease progressing when radiotherapy was added to the standard of care whole-body therapy, including chemotherapy [···]

Primary amoebic meningoencephalitis (PAM), a parasitic disease that causes the rapid deterioration of brain tissue, is one of the most lethal infections known, with a fatality rate exceeding 97%. [···]

Mayo Clinic scientists have uncovered surprising new insights into 'zombie cells,' aging cells that linger in the body and contribute to inflammation and disease. Seven studies reveal why these [···]

Finding practical ways to analyse the state of a person's immune system could guide treatment decisions and create opportunities for disease prevention.

Two Michigan cardiologists argue in JAMA Internal Medicine that gene therapies aimed at common diseases need a far higher safety bar than rare-disease treatments did.